The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosis
Open accessAbstract
Palliative care is defined as multidisciplinary, specialized medical care that addresses the physical, spiritual, and psychosocial needs of patients with serious illness and their caregivers.[1, 2] The benefits of palliative care are increasingly recognized across disease states and for patients with decompensated cirrhosis (DC).[3-5] This American Association for the Study of Liver Diseases (AASLD) guidance to providing palliative care for patients with cirrhosis was developed with the support and oversight of the AASLD Practice Guidelines Committee. The AASLD Practice Guidelines Committee chose to commission a guidance, rather than a guideline, because of the paucity of randomized controlled trials (RCTs) on this topic. AASLD guidelines are supported by systematic reviews of the literature, formal ratings of evidence quality and strength of recommendations, and, if appropriate, meta-analysis of results using the Grading of Recommendations Assessment Development and Evaluation system. In contrast, this document was developed by consensus of an expert panel and provides guidance statements based on formal review and analysis of the literature on the topics and questions related to the palliative care needs of patients with cirrhosis and their caregivers. Although palliative care can be considered regardless of the stage of cirrhosis, this guidance document predominantly addresses issues pertinent to adult patients with DC because this group bears considerable physical, psychosocial, and financial burden. We specifically focus on topics that are not covered in existing AASLD practice guidelines/guidance documents and thus refer the readers to the AASLD practice guidelines for specific recommendations for the diagnosis and management of ascites, hepatic encephalopathy (HE), hepatocellular carcinoma (HCC), and portal hypertension.[6-9] In addition, the complex palliative care needs for patients with HCC are not specifically addressed by this guidance, but are addressed by other guidelines.[10, 11] Palliative care can be provided at any stage of a serious illness and concurrently with disease-directed and curative treatments (including organ transplants). Over the past decade, the body of evidence supporting early palliative care has expanded to include persons with nonmalignant conditions, such as cirrhosis.[3, 4] Palliative care takes a comprehensive, person-centered approach to care, focusing on the aspects of care most important to patients and their families/informal caregivers. Because of this comprehensive scope, management typically relies on a team, including physicians, nurses, chaplains, social workers, and other providers. Table 1 illustrates the conceptual distinctions between primary and specialty palliative care. Specialty palliative care refers to care delivered by specialists with advanced palliative care skills such as board-certified palliative care physicians or palliative-certified nurses, social workers, pharmacists, and chaplains.[12] However, primary palliative care describes care aligned with the principles of palliative care (e.g., person-centered, communication-focused symptom management) that can be delivered by any medical professional.[12] The National Consensus Project for Quality Palliative Care defined eight core domains of high-quality palliative care around which this guidance is framed (Figure 1).[13, 14] Although all eight domains can apply to patients with DC, their relative importance may vary across the illness trajectory.[5, 15] Advance care planning (ACP) is a component of palliative care that involves the iterative and longitudinal process of medical decision making for patients and their families over the course of their illness trajectory.[16, 17] ACP includes identifying surrogate decision makers, illness education and prognostic disclosure, and formal documentation of goals for medical and end-of-life care (EoLC) through advance directives that center on the goals, values, and preferences of patients and their families.[17] Hospice is EoLC focused on allowing people in the last phases of incurable disease to live as fully and comfortably as possible.[14] Hospice is different than palliative care in that it focuses exclusively on comfort, rather than disease-directed curative treatment, and includes only persons with a life expectancy measured in months. In the USA, the hospice benefit is provided under Medicare Part A, and patients must have a defined, time-limited prognosis (certified by one or more physicians as ≤6 months).[18] DC is in many cases incurable, and life expectancy, which can be predicted with models such as the Model for End-Stage Liver Disease (MELD) and Child-Pugh-Turcotte scores, may be well below 6 months.[6, 19-21] Because of the poor prognosis of DC, many patients with DC qualify for hospice benefits, which can help support patients and their caregivers. Attention to patients' families and support persons, herein called caregivers, is a core v
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000678 · Cited by 7,482
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.6358 · Cited by 2,169
Sudore, R. L., Lum, H. D., You, J. J., Hanson, L. C., Meier, D. E., Pantilat, S. Z., Matlock, D. D., Rietjens, J. A. C., Korfage, I. J., Ritchie, C. S., et al. (2017) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2016.12.331 · Cited by 1,726
Bakitas, M., Lyons, K. D., Hegel, M. T., Balan, S., Brokaw, F. C., Seville, J., Hull, J. G., Li, Z., Tosteson, T. D., Byock, I. R., et al. (2009) · JAMA · doi:10.1001/jama.2009.1198 · Cited by 1,726
Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths
Bohnert, A. S. B. (2011) · JAMA · doi:10.1001/jama.2011.370 · Cited by 1,509
Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis
Trauer, J. M., Qian, M. Y., Doyle, J. S., Rajaratnam, S. M. W., & Cunnington, D. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2841 · Cited by 1,053
Dyspnea: Mechanisms, Assessment, and Management: A Consensus Statement
(1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.ats898 · Cited by 1,052
Krebs, E. E., Gravely, A., Nugent, S., Jensen, A. C., DeRonne, B., Goldsmith, E. S., Kroenke, K., Bair, M. J., & Noorbaloochi, S. (2018) · JAMA · doi:10.1001/jama.2018.0899 · Cited by 983
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
Palliative Care in Heart Failure
Rogers, J. G., Patel, C. B., Mentz, R. J., Granger, B. B., Steinhauser, K. E., Fiuzat, M., Adams, P. A., Speck, A., Johnson, K. S., Krishnamoorthy, A., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.030 · Cited by 603
Levis, B., Sun, Y., He, C., Wu, Y., Krishnan, A., Bhandari, P. M., Neupane, D., Imran, M., Brehaut, E., Negeri, Z., et al. (2020) · JAMA · doi:10.1001/jama.2020.6504 · Cited by 577
The Role of Cytokines in Sleep Regulation
Krueger, J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786549281 · Cited by 507
Hospital readmissions among patients with decompensated cirrhosis
Volk, M. L., Tocco, R. S., Bazick, J., Rakoski, M. O., & Lok, A. S. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.314 · Cited by 451
Bergasa, N. V., Alling, D. W., Talbot, T. L., Swain, M. G., Yurdaydin, C., Turner, M. L., Schmitt, J. M., Walker, E. C., & Jones, E. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-3-199508010-00001 · Cited by 365
Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study
Wolfhagen, F., Sternieri, E., Hop, W., Vitale, G., Bertolotti, M., & Van Buuren, H. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322521 · Cited by 343
Peng, J.-K., Hepgul, N., Higginson, I. J., & Gao, W. (2019) · Palliative Medicine · doi:10.1177/0269216318807051 · Cited by 283
High prevalence of sleep disturbance in cirrhosis
Córdoba, J., Cabrera, J., Lataif, L., Penev, P., Zee, P., & Blei, A. T. (1998) · Hepatology · doi:10.1002/hep.510270204 · Cited by 273
Pharmacological treatments for fatigue associated with palliative care
Mücke, M., Mochamat, M., Cuhls, H., Peuckmann-Post, V., Minton, O., Stone, P., & Radbruch, L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006788.pub3 · Cited by 227
Rakoski, M. O., McCammon, R. J., Piette, J. D., Iwashyna, T. J., Marrero, J. A., Lok, A. S., Langa, K. M., & Volk, M. L. (2012) · Hepatology · doi:10.1002/hep.24616 · Cited by 190
Tandon, P., Rowe, B. H., Vandermeer, B., & Bain, V. G. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01200.x · Cited by 176
Bakitas, M. A., Dionne-Odom, J. N., Ejem, D. B., Wells, R., Azuero, A., Stockdill, M. L., Keebler, K., Sockwell, E., Tims, S., Engler, S., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.2861 · Cited by 170
Khurana, S., & Singh, P. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01326.x · Cited by 162
Provider Tools for Advance Care Planning and Goals of Care Discussions: A Systematic Review
Myers, J., Cosby, R., Gzik, D., Harle, I., Harrold, D., Incardona, N., & Walton, T. (2018) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909118760303 · Cited by 135
Nardelli, S., Pentassuglio, I., Pasquale, C., Ridola, L., Moscucci, F., Merli, M., Mina, C., Marianetti, M., Fratino, M., Izzo, C., et al. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-012-9364-0 · Cited by 114
Dionne-Odom, J. N., Ejem, D. B., Wells, R., Azuero, A., Stockdill, M. L., Keebler, K., Sockwell, E., Tims, S., Engler, S., Kvale, E., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.2583 · Cited by 103
Ekström, M., Ahmadi, Z., Bornefalk-Hermansson, A., Abernethy, A., & Currow, D. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006429.pub3 · Cited by 98
Effect of oral naltrexone on pruritus in cholestatic patients
Mansour-Ghanaei, F. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i7.1125 · Cited by 89
Silveira, M. G., Gossard, A. A., Stahler, A. C., Jorgensen, R. A., Petz, J. L., Ali, A. H., & Lindor, K. D. (2017) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000387 · Cited by 64
Buganza‐Torio, E., Mitchell, N., Abraldes, J. G., Thomas, L., Ma, M., Bailey, R. J., & Tandon, P. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15068 · Cited by 60
De Rui, M., Middleton, B., Sticca, A., Gatta, A., Amodio, P., Skene, D. J., & Montagnese, S. (2015) · Neurochemical Research · doi:10.1007/s11064-014-1414-z · Cited by 51
Wilson, M., Finlay, M., Orr, M., Barbosa-Leiker, C., Sherazi, N., Roberts, M. L. A., Layton, M., & Roll, J. M. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.04.019 · Cited by 46
Cited by
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Singal, A. G., Llovet, J. M., Yarchoan, M., Mehta, N., Heimbach, J. K., Dawson, L. A., Jou, J. H., Kulik, L. M., Agopian, V. G., Marrero, J. A., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000466 · Cited by 2,052
“[339] 50.”
Liver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Bataller, R., Arab, J. P., & Shah, V. H. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2207599 · Cited by 259
Metadata
- Authors
- Rogal, S. S., Hansen, L., Patel, A., Ufere, N. N., Verma, M., Woodrell, C. D., & Kanwal, F.
- Venue
- Hepatology
- Published
- 2022-04-22
- Volume
- 76
- Issue
- 3
- Pages
- 819-853
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W4210483174
- Cited by
- 210
- References
- 32
- FWCI
- 31.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.